Page 2 - Although Eupraxia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Although Eupraxia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Although Eupraxia Today - Breaking & Trending Today

Eupraxia Pharmaceuticals Reports Positive Topline Data in its Phase 2b Osteoarthritis Trial with EP-104IAR

Published: June 26, 2023

/PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a clinical-stage biotechnology company with an innovative drug delivery...

Source: prnewswire.com

Related Topics:

Czech RepublicCompany PhaseOsteoarthritis Research Society InternationalAmerican College Of RheumatologyUs Centers For DiseaseEupraxia Pharmaceuticals IncArthritis FoundationEupraxia PharmaceuticalsArea UnderAbout PhaseOutcome MeasuresDisease ControlAmerican CollegeRegarding Forward Looking StatementsAlthough Eupraxia

Eupraxia Pharmaceuticals Reports Third Quarter 2022 Financial Results

Published: November 7, 2022

/CNW/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a Phase 2 clinical-stage biotechnology company with an innovative drug...

Source: newswire.ca

Related Topics:

Czech RepublicUnited KingdomVik PeckPaul BrennanJames HelliwellAdam PeelerLife Sciences Company Of The Year AwardInternational Financial Reporting StandardsEupraxia Pharmaceuticals IncCompany PhaseEupraxia Audit CommitteeLife Sciences British ColumbiaOrphan DrugChief Business OfficerFinancial HighlightsEmerging Life Sciences CompanyYear AwardLife Sciences BritishChief BusinessData Safety Monitoring BoardMagnetic Resonance ImagingManagement DiscussionAudit CommitteeRegarding Forward Looking StatementsAlthough Eupraxia